SAP SE (SAP)
NYSE: SAP
· Real-Time Price · USD
293.34
-8.40 (-2.78%)
At close: Jun 13, 2025, 3:59 PM
293.36
0.01%
After-hours: Jun 13, 2025, 05:40 PM EDT
-2.78% (1D)
Bid | 293 |
Market Cap | 342.21B |
Revenue (ttm) | 35.15B |
Net Income (ttm) | 5.73B |
EPS (ttm) | 5.56 |
PE Ratio (ttm) | 52.76 |
Forward PE | 37.47 |
Analyst | Buy |
Ask | 296 |
Volume | 1,381,467 |
Avg. Volume (20D) | 1,443,234 |
Open | 293.77 |
Previous Close | 301.74 |
Day's Range | 292.38 - 296.17 |
52-Week Range | 186.50 - 311.40 |
Beta | 0.94 |
Analyst Forecast
According to 0 analyst ratings, the average rating for SAP stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts1 month ago
+7.56%
SAP shares are trading higher after the company re...
Unlock content with
Pro Subscription
1 month ago
+0.74%
SAP shares are trading higher after the company reported better-than-expected Q1 EPS results.

2 weeks ago · seekingalpha.com
Taysha: TSHA-102 Presses On With IND Part B Protocol And SAP AmendmentsTaysha Gene Therapies, Inc. achieved positive updated data from Part A of the phase 1/2 REVEAL study using TSHA-102 to treat patients with Rett Syndrome. Alignment gained with FDA on IND amendments to...